생체 재료 창상 드레싱 시장 - 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Biomaterial Wound Dressing Market Growth & Trends:

The global biomaterial wound dressing market is expected to reach USD 10.21 billion by 2030, registering a CAGR of 7.46% in the forecast period, according to a new report by Grand View Research, Inc. Advances in biomaterial technology, which have led to the development of innovative and effective wound care products, rising prevalence of chronic diseases, improving healthcare infrastructure in emerging economies, are the key driving factors propel the biomaterial wound dressing market over the forecast period.

Moreover, the biomaterial wound dressing market has seen significant growth over the last few decades, owing to increasing product launches by key players, and rising R&D activities. For instance, in January 2023, Convatec introduced ConvaFoam, a range of advanced foam dressings that cater to the requirements of both healthcare providers and patients. ConvaFoam's versatility makes it an ideal dressing option for managing wounds and safeguarding the skin, as it can be used for various wound types, regardless of the wound's healing stage.

Similarly, in August 2023, Medela launched the Invia Integrated Dressing, which is designed to cater to all types of wounds, including closed surgical incisions. The sterile dressing can be utilized in both hospital and home settings for a period of up to seven days. As a result, product launches with additional benefits are expected to increase market growth for these biomaterial wound dressings over the projection period.

The rising prevalence of chronic disorders, such as diabetes and obesity has led to an increase in the number of patients with chronic wounds. Biomaterial wound dressings have been found to be effective in treating these wounds, which has driven demand for these products. For instance, according to WHO, in 2023, diabetes is a global health concern, with approximately 422 million people affected globally, mostly in low- and middle-income countries. Every year, 1.5 million deaths are directly linked to diabetes. The prevalence and number of cases of diabetes have been on a steady rise over the past few decades. These factors are expected to drive market growth over the forecast period.

Biomaterial Wound Dressing Market Report Highlights:

• In terms of product, natural wound dressing segment held the largest market share in 2023. This growth can be anticipated due to the rising incidences of diabetic foot ulcers and pressure ulcers
• In terms of application, the chronic wounds segment held the largest market share in 2023, owing to rising geriatric populations along with the rising chronic wounds are driving the segment growth
• In terms of end use, hospitals segment held the largest share in 2023. Hospitals often adopt advanced wound care technologies and treatments to optimize patient outcomes
• North America is expected to dominate the biomaterial wound dressing market growth over the forecast period owing to the well-developed healthcare infrastructure and large presence of key players operating in the market

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Biomaterial Wound Dressing Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Increasing number of accidents
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Technological advancements in wound dressings
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Stringent manufacturing policies
• 3.3. Biomaterial Wound Dressing Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Biomaterial Wound Dressing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Biomaterial Wound Dressing Market: Product Movement Analysis, USD Million, 2023 & 2030
• 4.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Natural
  • 4.4.1. Natural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Alginate
    • 4.4.2.1. Alginate market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.3. Honey
    • 4.4.3.1. Honey market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.4. Collagen
    • 4.4.4.1. Collagen market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.5. Chitosan
    • 4.4.5.1. Chitosan market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.6. Carboxymethyl cellulose (CMC)
    • 4.4.6.1. Carboxymethyl cellulose (CMC) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
• 4.5. Synthetic
  • 4.5.1. Synthetic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Polyurethane
    • 4.5.2.1. Polyurethane market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5.3. Silicone
    • 4.5.3.1. Silicone market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5.4. Others
    • 4.5.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)

Chapter 5. Biomaterial Wound Dressing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Biomaterial Wound Dressing Market: Application Movement Analysis, USD Million, 2023 & 2030
• 5.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Diabetic foot ulcer
    • 5.4.2.1. Diabetic foot ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.3. Pressure ulcer
    • 5.4.3.1. Pressure ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.4. Venous leg ulcer
    • 5.4.4.1. Venous leg ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.5. Others
    • 5.4.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Surgical & traumatic wounds
    • 5.5.2.1. Surgical & traumatic wounds market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns market revenue estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6. Biomaterial Wound Dressing Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Biomaterial Wound Dressing Market: End Use Movement Analysis, USD Million, 2023 & 2030
• 6.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Home healthcare
  • 6.6.1. Home healthcare market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Research & Manufacturing
  • 6.7.1. Research & manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biomaterial Wound Dressing Market: Regional Estimates & Trend Analysis by Product, Application, & End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Mexico biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Argentina biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. South Africa
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. South Africa biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. ConvaTec Group PLC
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Smith & Nephew PLC
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Molnlycke Health Care AB
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. B. Braun Melsungen AG
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. 3M
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. URGO Medical
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Coloplast Corp.
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Integra LifeSciences
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Medline Industries, Inc.
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives